Idoate M - Search Results

1

p53 expression in cutaneous malignant melanoma: an immunohistochemical study of 87 cases of primary, recurrent, and metastatic melanoma.

Barnhill RL, Castresana JS, Rubio MP, Martin MT, Idoate M, Vazquez JJ, Thor AD. Barnhill RL, et al. Among authors: idoate m. Mod Pathol. 1994 Jun;7(5):533-5. Mod Pathol. 1994. PMID: 7937717

2

Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.

Castresana JS, Rubio MP, Vázquez JJ, Idoate M, Sober AJ, Seizinger BR, Barnhill RL. Castresana JS, et al. Among authors: idoate m. Int J Cancer. 1993 Oct 21;55(4):562-5. doi: 10.1002/ijc.2910550407. Int J Cancer. 1993. PMID: 8104906

3

Anion exchanger immunoreactivity in human salivary glands in health and Sjögren's syndrome.

Vázquez JJ, Vázquez M, Idoate MA, Montuenga L, Martínez-Ansó E, Castillo JE, García N, Medina JF, Prieto J. Vázquez JJ, et al. Among authors: idoate ma. Am J Pathol. 1995 Jun;146(6):1422-32. Am J Pathol. 1995. PMID: 7778681 Free PMC article.

4

Regression mechanism of cyanamide-induced inclusion bodies in the rat: a useful experimental pattern to study the beta-glycogen metabolization of hepatocytes.

Idoate MA, Vázquez JJ. Idoate MA, et al. Int J Exp Pathol. 1992 Dec;73(6):699-708. Int J Exp Pathol. 1992. PMID: 1337264 Free PMC article.

5

Chromosome 17 allelic loss and NF1-GRD mutations do not play a significant role as molecular mechanisms leading to melanoma tumorigenesis.

Gómez L, Rubio MP, Martin MT, Vázquez JJ, Idoate M, Pastorfide G, Pestaña A, Seizinger BR, Barnhill RL, Castresana JS. Gómez L, et al. Among authors: idoate m. J Invest Dermatol. 1996 Mar;106(3):432-6. doi: 10.1111/1523-1747.ep12343578. J Invest Dermatol. 1996. PMID: 8648172 Free article.

6

Rectal biopsy as a diagnostic procedure of chronic visceral leishmaniasis.

Idoate MA, Vazquez JJ, Civeira P. Idoate MA, et al. Histopathology. 1993 Jun;22(6):589-90. doi: 10.1111/j.1365-2559.1993.tb00182.x. Histopathology. 1993. PMID: 8354491 No abstract available.

7

Diagnosis of Lafora's disease in apocrine sweat glands of the axilla.

Idoate MA, Vazquez JJ, Soto J, de Castro P. Idoate MA, et al. Am J Dermatopathol. 1991 Aug;13(4):410-3. doi: 10.1097/00000372-199108000-00013. Am J Dermatopathol. 1991. PMID: 1656810

8

APR-246 combined with 3-deazaneplanocin A, panobinostat or temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells.

De La Rosa J, Urdiciain A, Zelaya MV, Zazpe I, Meléndez B, Rey JA, Idoate MA, Castresana JS. De La Rosa J, et al. Int J Oncol. 2021 Mar;58(3):312-330. doi: 10.3892/ijo.2021.5177. Epub 2021 Jan 26. Int J Oncol. 2021. PMID: 33650649

9

Tubastatin A, an inhibitor of HDAC6, enhances temozolomide‑induced apoptosis and reverses the malignant phenotype of glioblastoma cells.

Urdiciain A, Erausquin E, Meléndez B, Rey JA, Idoate MA, Castresana JS. Urdiciain A, et al. Int J Oncol. 2019 May;54(5):1797-1808. doi: 10.3892/ijo.2019.4739. Epub 2019 Mar 1. Int J Oncol. 2019. PMID: 30864703

10

The synergistic effect of DZ‑NEP, panobinostat and temozolomide reduces clonogenicity and induces apoptosis in glioblastoma cells.

De La Rosa J, Urdiciain A, Zazpe I, Zelaya MV, Meléndez B, Rey JA, Idoate MA, Castresana JS. De La Rosa J, et al. Int J Oncol. 2020 Jan;56(1):283-300. doi: 10.3892/ijo.2019.4905. Epub 2019 Oct 30. Int J Oncol. 2020. PMID: 31746375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters